MX2009003683A - Sistema antimicrobiano e inmunoestimulador que comprende una enzima de oxido-reductasa. - Google Patents

Sistema antimicrobiano e inmunoestimulador que comprende una enzima de oxido-reductasa.

Info

Publication number
MX2009003683A
MX2009003683A MX2009003683A MX2009003683A MX2009003683A MX 2009003683 A MX2009003683 A MX 2009003683A MX 2009003683 A MX2009003683 A MX 2009003683A MX 2009003683 A MX2009003683 A MX 2009003683A MX 2009003683 A MX2009003683 A MX 2009003683A
Authority
MX
Mexico
Prior art keywords
antimicrobial
oxidoreductase enzyme
present
immunostimulatory
immunostimulatory system
Prior art date
Application number
MX2009003683A
Other languages
English (en)
Spanish (es)
Inventor
John Reginald Barrett
James Joseph Brennan
Thomas Patrick Patton
Original Assignee
Inst Of Technology Sligo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Technology Sligo filed Critical Inst Of Technology Sligo
Publication of MX2009003683A publication Critical patent/MX2009003683A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/11—Peroxy compounds, peroxides, e.g. hydrogen peroxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2009003683A 2006-10-06 2007-10-05 Sistema antimicrobiano e inmunoestimulador que comprende una enzima de oxido-reductasa. MX2009003683A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0619786.7A GB0619786D0 (en) 2006-10-06 2006-10-06 An antimicrobial and immunostimulatory system
PCT/IE2007/000094 WO2008041218A1 (en) 2006-10-06 2007-10-05 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme

Publications (1)

Publication Number Publication Date
MX2009003683A true MX2009003683A (es) 2009-08-20

Family

ID=37454109

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003683A MX2009003683A (es) 2006-10-06 2007-10-05 Sistema antimicrobiano e inmunoestimulador que comprende una enzima de oxido-reductasa.

Country Status (14)

Country Link
US (2) US20100135926A1 (enExample)
EP (1) EP2068949B1 (enExample)
JP (1) JP5563822B2 (enExample)
AT (1) ATE549040T1 (enExample)
AU (1) AU2007303769B2 (enExample)
CA (1) CA2665531C (enExample)
ES (1) ES2384654T3 (enExample)
GB (1) GB0619786D0 (enExample)
IE (1) IE20070710A1 (enExample)
IL (1) IL197900A (enExample)
MX (1) MX2009003683A (enExample)
NZ (1) NZ576754A (enExample)
WO (1) WO2008041218A1 (enExample)
ZA (1) ZA200902992B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7837719B2 (en) 2002-05-09 2010-11-23 Daemen College Electrical stimulation unit and waterbath system
PL2276484T3 (pl) * 2008-03-26 2016-12-30 Mieszanina o działaniu przeciwdrobnoustrojowym
WO2010082846A1 (en) * 2008-12-24 2010-07-22 Comvita New Zealand Limited Medical and nutritional formulations
GB0907553D0 (en) * 2009-05-01 2009-06-10 Insense Ltd Treatment of human or animal body surface infection
NZ600269A (en) * 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
EA019332B1 (ru) * 2009-09-29 2014-02-28 Юнайтед Текнолоджис Ут Аг Состав для ухода за полостью рта, содержащий человеческий рекомбинантный интерлейкин-1
EP2510944A1 (en) 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
AU2012330202A1 (en) * 2011-10-27 2014-06-12 Healthcare Systems Novel compound contained in manuka honey and use of same
JP5750404B2 (ja) * 2012-06-14 2015-07-22 株式会社山田蜂蜜研究所 抗菌剤及び化粧料
WO2013188497A2 (en) * 2012-06-15 2013-12-19 Agentase, Llc, A Subsidiary Of Flir Systems, Inc. A smart, self-decontaminating polymer and method for inhibiting the growth of a bacteria and fungus
WO2014138723A2 (en) * 2013-03-08 2014-09-12 Cognate3 Llc Physical optimization beverage
EP3626310A1 (en) 2013-05-27 2020-03-25 Rakuto Bio Technologies Ltd. Enzymatic system containing cosmetic compositions
GB2552572B (en) * 2014-04-30 2019-01-16 Matoke Holdings Ltd Antimicrobial compositions
JP6825913B2 (ja) * 2014-04-30 2021-02-03 マトケ・ホールディングス・リミテッド 抗菌組成物
CA2968308A1 (en) * 2014-11-24 2016-06-02 Matoke Holdings Limited Prevention and treatment of microbial infections
EP3253424B1 (en) * 2015-02-03 2020-12-09 Matoke Holdings Limited Antimicrobial fibers and compositions
GB201509044D0 (en) 2015-05-27 2015-07-08 Systagenix Wound Man Ip Co Bv Composition
MA42910A (fr) * 2015-07-23 2018-05-30 Matoke Holdings Ltd Compositions antimicrobiennes et formulations libérant du peroxyde d'hydrogène
JP2019533661A (ja) * 2016-10-06 2019-11-21 マトケ・ホールディングス・リミテッド 抗微生物組成物
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN112105378B (zh) * 2018-01-03 2025-03-11 宾夕法尼亚州研究基金会 作为新生儿抗惊厥药的葡萄糖氧化酶组合物
US11525063B2 (en) 2018-02-28 2022-12-13 The Board Of Trustees Of Western Michigan University Fluorescent oxygen sensing ink
CN108795890A (zh) * 2018-07-30 2018-11-13 上海理工大学 一种获取重组大肠杆菌中丙酮酸氧化酶的方法
WO2020193993A2 (en) 2019-03-27 2020-10-01 Matoke Holdings Limited Antimicrobial compositions
GB2589863A (en) * 2019-12-09 2021-06-16 Institute Of Tech Sligo Antimicrobial composition
GB2589862A (en) 2019-12-09 2021-06-16 Institute Of Tech Sligo Antimicrobial composition
WO2021186165A1 (en) 2020-03-16 2021-09-23 Matoke Holdings Limited Antimicrobial compositions
TW202304479A (zh) 2021-04-14 2023-02-01 美商普瑞納動物營養有限公司 使用產生過氧化氫之組成物減緩隱胞子蟲病
WO2023227599A1 (en) 2022-05-23 2023-11-30 Atlantic Technological University Antimicrobial coating composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578265A (en) * 1981-08-13 1986-03-25 Laclede Professional Products, Inc. Di-enzymatic dentifrice
JPS59231011A (ja) * 1983-06-06 1984-12-25 ラクレ−デ・プロフエツシヨナル・プロダクツ・インコ−ポレ−テツド 二酵素糸歯みがき
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
CA1287584C (en) 1986-09-02 1991-08-13 Seiichi Komori Wound-healing preparations
DK501686A (da) * 1986-10-20 1988-04-21 Otto Melchior Poulsen Enzymholdigt, baktericidt middel samt tandplejemidler og saarbehandlingsmidler, som indeholder det
US4839156A (en) * 1987-04-17 1989-06-13 Colgate-Palmolive Company Stable hydrogen peroxide dental gel
US4950475A (en) * 1988-07-19 1990-08-21 Imaginative Research Associates, Inc. Novel film-forming gels with high concentrations of humectants and emollients
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
US5098303A (en) * 1990-03-22 1992-03-24 Ultradent Products, Inc. Method for bleaching teeth
US5756090A (en) * 1991-02-21 1998-05-26 Eoe, Inc. Oxygen activatable formulations for disinfection or sterilization
US5262151A (en) * 1991-11-25 1993-11-16 Montgomery Robert E Stabilized enzymatic antimicrobial compositions
US5453284A (en) 1993-01-29 1995-09-26 Pellico; Michael A. Stabilized enzymatic dentifrice
US5336494A (en) 1993-01-29 1994-08-09 Pellico Michael A Pet chewable products with enzymatic coating
ATE246522T1 (de) * 1998-06-19 2003-08-15 Oxibio Inc Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften
FI111332B (fi) 2001-04-09 2003-07-15 Kari Viherlahti Menetelmä hoitotuotteen valmistamiseksi ja hoitotuote
CA2483214C (en) * 2002-04-24 2012-05-29 Insense Limited Wound dressings comprising hydrated hydrogels and enzymes
US20030228264A1 (en) * 2002-06-06 2003-12-11 Perna Salvatore F. Dissolvable teeth whitening apparatus

Also Published As

Publication number Publication date
US20100135926A1 (en) 2010-06-03
GB0619786D0 (en) 2006-11-15
AU2007303769A1 (en) 2008-04-10
AU2007303769A2 (en) 2009-06-25
JP2010505817A (ja) 2010-02-25
WO2008041218A1 (en) 2008-04-10
JP5563822B2 (ja) 2014-07-30
IE20070710A1 (en) 2008-06-11
ZA200902992B (en) 2010-02-24
IL197900A0 (en) 2011-08-01
HK1128637A1 (en) 2009-11-06
EP2068949B1 (en) 2012-03-14
CA2665531A1 (en) 2008-04-10
ATE549040T1 (de) 2012-03-15
ES2384654T3 (es) 2012-07-10
AU2007303769B2 (en) 2014-04-03
CA2665531C (en) 2017-01-24
NZ576754A (en) 2012-02-24
EP2068949A1 (en) 2009-06-17
US20140023597A1 (en) 2014-01-23
IL197900A (en) 2014-11-30
US9522177B2 (en) 2016-12-20

Similar Documents

Publication Publication Date Title
ZA200902992B (en) Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme
MX2011000793A (es) Metodos, sistemas y composiciones para incrementada tolerancia de microorganismos a y produccion de acido 3-hidroxipropionico (3-hp).
MX2008004966A (en) A composition comprising a coupled enzyme system
FI20050913A0 (fi) Menetelmä peroksihappojen valmistamiseksi
AU2016204193A1 (en) Selective Lysis of Cells
MX2008014625A (es) Metodos y composiciones para la produccion y transporte controlados y sostenidos de peroxidos.
IL185796A0 (en) Process for the manufacture of cellulose sulfate with improved characteristics
EP3623465A3 (en) Production of fatty acids and derivatives thereof
MX2011013682A (es) Solucion que contiene acido hipocloroso y metodos para usar la misma.
DE602006020875D1 (de) Oberflächenaktive peroxycarbonsäurezusammensetzungen
AU2003258187A1 (en) Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives
MX356086B (es) Produccion de acidos grasos y derivados de los mismos.
MY147478A (en) Microbiologically stabilised beer
EP2073836A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VAGINAL DISEASES USING ENZYMES PRODUCING PEROXIDE AND PEROXIDASES
AR064890A1 (es) Blanqueo de substratos
WO2007135188A3 (en) Process for the preparation of l-methionine
TW200700545A (en) Chemical mechanical polishing aqueous dispersion, chemical mechanical polishing method, and kit for preparing chemical mechanical polishing aqueous dispersion
MX2012003916A (es) Cepas bacterianas y variantes de las mismas que pueden degradar el acido polilactico y sus usos.
WO2007011845A3 (en) Use of a bacillus meti gene to improve methionine production in microorganisms
WO2010064262A3 (en) A process for production of water soluble melanin using a strain of the fungus gliocephalotrichum
MX2009000461A (es) Composiciones y metodos para reducir o prevenir el crecimiento o supervivencia de los microorganismos en medios acuosos.
WO2006102722A8 (en) Process for the production of ϝ-glutamylcysteine
PL1831239T3 (pl) Sposób wytwarzania gamma-laktonu kwasu 17-hydroksy-6 beta, 7 beta,15 beta, 16 beta-bismetyleno-17 alpha-pregn-4-en-3-ono-21-karboksylowego i związki pośrednie kluczowe dla tego sposobu
SI2016073T1 (sl) Postopek za pripravo ÄŤistega irbesartana
WO2011055216A4 (en) A plant nutrient obtained from the rice husk and a process of preparation thereof

Legal Events

Date Code Title Description
FG Grant or registration